Australians back bacterial theory for bowel disease

Article Abstract:

Thomas Borody, Director of Centre for Digestive Diseases in Sydney, has concocted a mixture of three antibiotics rifabutin, clarithromycin and clofazimine to treat Crohn's disease, which has shown promising results in small-scale clinical trials. He is convinced that, as in the case of stomach ulcers, Crohn's is caused by infection with bacteria not normally found in the intestine.

Research, Australia, Crohn's disease, Clofazimine, Clarithromycin, Rifabutin, Borody, Thomas

---

Blocking bacterial enterotoxins

Article Abstract:

Shiga toxin, or verotoxin, is an important part of how Escherichia coli attacks the body. Recent research offers means to clear the toxin from the intestine with synthetic carbohydrate determinants or other synthetic complexes.

Enterotoxins

---

A new biological agent for treatment of Shiga toxigenic Escherichia coli infections and dysentery in humans

Article Abstract:

A recombinant bacterium has been constructed that absorbed and netralized the Shiga toxins in Escherichia coli infection in mice. This bacterium shows promise as a way to treat E. coli infection and dysentery.

Dysentery

Similar abstracts:

• Abstracts: Transfusion reaction associated with duration of storage. Superinfection with second virus strain is reported in humans
• Abstracts: Back pain in the older patient. Association between osteoarthritis of the hand and knee in a population of skeletons from London
• Abstracts: Managing chemotherapy for tuberculosis. Managing occupational health services in NHS trusts
• Abstracts: Closet case. Kate Betts' closet is more than a reminder of sizes past. It's a lush chronicle of her personal history

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.